Hyperfine Inc. has promoted two neuroradiologists, Edmond Knopp, M.D., and Chip Truwit, M.D., as vice president of medical affairs and vice president of scientific affairs, respectively.

“These leadership appointments underscore our commitment to developing ultra-low-field MR brain imaging to advance brain health,” Hyperfine President/CEO Maria Sainz said. “We are proud and fortunate to entrust Drs. Knopp and Truwit to provide the medical and scientific expertise and guide our development, clinical, and commercial efforts with ultra-low-field brain imaging.”
 
As vice president of medical affairs, Knopp interfaces with medical professionals, guides clinical studies, and champions the company’s commitment to further ultra-low-field brain imaging to advance brain health, particularly in stroke care and disease-modifying therapies for Alzheimer’s.
 
Joining Hyperfine in 2021, Knopp has three decades of experience in radiology, neuroradiology, and MR imaging. A faculty member and leader at the New York University School of Medicine Department of Radiology, Knopp holds positions as a Senior American Society of Neuroradiology member and was an American Board of Radiology examiner. He was honored with the 2015 American Board of Radiology Lifetime Service Award, has been an advisor to the acclaimed International Diagnostic Course in Radiology (Neuroradiology) Davos, and was inducted as a fellow in the American Society of Functional Neuroradiology.

Knopp earned a bachelor of science degree in biology from Emory University and his doctor of medicine from SUNY Downstate Medical Center.
 
As vice president of scientific affairs, Truwit spearheads clinical innovation projects, supporting the Swoop system’s continued advancement. With a background rich in pediatric neuroradiology and the healthcare industry, Truwit is well-positioned at Hyperfine, Inc. to focus on the company’s future technology developments supporting global brain health and expanded access to care.
 
Truwit joined Hyperfine in 2022 and has more than three decades of experience in academic and clinical radiology. He previously served as the chief innovation officer and chief of radiology at Hennepin Healthcare, chief medical officer of Diagnostic Imaging at Philips, and emeritus professor of radiology at the University of Minnesota. Truwit co-founded Image-guided Neurologics, which exited to Medtronic in 2005. He holds 29 patents, has authored more than 130 neuroscience articles and four books, and is an internationally recognized lecturer on the imaging of pediatric neuroimaging, head trauma, and stroke.

Truwit earned his bachelor of science degree in international politics and doctor of medicine degree at Georgetown University. He completed his neuroradiology training at the University of California, San Francisco.
 
Hyperfine is redefining brain imaging with the Swoop system—the world’s first U.S. Food and Drug Administration (FDA)-cleared, portable, ultra-low-field, magnetic resonance brain imaging system capable of providing imaging at multiple points of care. The Swoop system received initial FDA clearance in 2020 as a portable magnetic resonance brain imaging device for producing images that display the internal structure of the head where a full diagnostic examination is not clinically practical. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis. The Swoop system has been approved for brain imaging in several countries, including Canada and Australia, has UKCA certification in the United Kingdom, CE certification in the European Union, and is also available in New Zealand. Hyperfine aims to revolutionize patient care globally through transformational, accessible, clinically relevant diagnostic imaging and data solutions. Founded by Dr. Jonathan Rothberg in a technology-based incubator called 4Catalyzer, Hyperfine scientists, engineers, and physicists developed the Swoop system to redefine brain imaging methodology and the ways clinicians can apply accessible diagnostic imaging to patient care. With the portable, ultra-low-field Swoop system, Hyperfine is redefining the neuroimaging workflow by bringing brain imaging to the patient’s bedside.